about
The burden of cholera in Uganda.Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.Case fatality rate and length of hospital stay among patients with typhoid intestinal perforation in developing countries: a systematic literature review.A Multi-country Study of the Household Willingness-to-Pay for Dengue Vaccines: Household Surveys in Vietnam, Thailand, and Colombia.Quality assurance and quality improvement using supportive supervision in a large-scale STI intervention with sex workers, men who have sex with men/transgenders and injecting-drug users in IndiaAn Estimation of Private Household Costs to Receive Free Oral Cholera Vaccine in Odisha, India.Impact of oral cholera vaccines in cholera-endemic countries: A mathematical modeling study.Oral Cholera Vaccination Delivery Cost in Low- and Middle-Income Countries: An Analysis Based on Systematic Review.Pursuing scale and quality in STI interventions with sex workers: initial results from Avahan India AIDS Initiative.Cost-effectiveness of asthma clinic approach in the management of chronic asthma in Australia.A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low- and middle-income countries to support vaccine introduction policy and decisions.Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment.Cost-of-illness of cholera to households and health facilities in rural Malawi.A multi-country study of the economic burden of dengue fever: Vietnam, Thailand, and Colombia.Updated estimates of typhoid fever burden in sub-Saharan Africa.Prevalence of specific learning disabilities among primary school children in a South Indian city.Considerations around the introduction of a cholera vaccine in Bangladesh.Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia.Estimating Typhoid Fever Risk Associated with Lack of Access to Safe Water: A Systematic Literature ReviewThe Euvichol story - Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnershipsTyphoid conjugate vaccines: a new tool in the fight against antimicrobial resistanceBarriers to typhoid fever vaccine access in endemic countriesThe health economics of cholera: A systematic reviewAssessment of Socio-Demographic Factors, Mother and Child Health Status, Water, Sanitation, and Hygienic Conditions Existing in a Hilly Rural Village of NepalA Multicenter Cost-of-Illness and Long-term Socioeconomic Follow-up Study in the Severe Typhoid Fever in Africa Program: Study ProtocolThe Severe Typhoid Fever in Africa Program: Study Design and Methodology to Assess Disease Severity, Host Immunity, and Carriage Associated With Invasive SalmonellosisThe Monitoring and Evaluation of a Multicountry Surveillance Study, the Severe Typhoid Fever in Africa ProgramSpatial and Temporal Patterns of Typhoid and Paratyphoid Fever Outbreaks: A Worldwide Review, 1990-2018An overview of VaxchoraTM, a live attenuated oral cholera vaccineThe history of OCV in India and barriers remaining to programmatic introductionCosting oral cholera vaccine delivery using a generic oral cholera vaccine delivery planning and costing tool (CholTool)
P50
Q35068034-F999AF85-51D5-4EE4-8581-138B6307D0E2Q35091828-CE139512-721E-4AB2-89FE-DE693D64BC8EQ35152027-987D0C3C-CF8D-4AFF-ADF1-4E3E985E760DQ35648537-58CFC69E-DAD5-4206-AFBD-C1E73B4DAD7EQ35656667-4D9529EA-B1ED-46E7-88E7-FD9F330F3A97Q35767575-253C6F1A-2B06-4981-AF47-9CC1B2EAF7ABQ35963349-CB008A1A-09FC-45A5-9A21-0F56F33CD697Q36215966-A72A53A3-F599-49E8-9CEF-D5F8CF9F49B4Q36928554-A02382A3-CB4B-413A-8876-7D6003163F89Q38111445-5A75832E-9B47-48A8-8442-D6BE903852DEQ38672074-CEB3F8FC-D499-4C63-9F3B-B560E9385BDBQ39115267-A9D1438D-FE29-4AAF-8137-AE38CBA3EF01Q41975750-B2AD802E-27EF-40A1-8B6C-D5D757FEA69EQ47127281-FA0C73D2-61F5-4EF5-83EB-268733A03FD8Q50085136-1B04129E-C31A-4C11-9C8D-38CB6AB01F4FQ50433073-8F62FEF8-8A6A-44AE-ACCF-958F64FED641Q51732904-3365C278-D791-404D-AB58-223481D59FF2Q52592212-E650EE21-4B43-4746-8F12-481BAD270B02Q56517610-01B7647B-A113-4336-94E1-11351EC1CDC2Q57481187-EAA58AED-37D7-42D0-A07D-D459B097AB58Q57927639-E97CB47E-8370-406D-8E62-9852EBA10E45Q57941639-E7E31388-F38E-4E10-A6FA-9F7D2B53848CQ89119685-F91A8D01-787F-471F-BC22-E2A623A237BAQ90803683-76DF0084-BFCD-4984-A54E-E56BE7DCAA41Q91008231-C7B3ED75-DAFD-48E5-A609-B9D0491698F7Q91008250-B59C72C9-2279-481E-9DC9-19E88E88D1D7Q91008255-958A3078-E037-441B-8E8A-1771D7A40997Q91008262-1BD433FB-C778-4FFD-A8DD-F09EE246A4ADQ92146366-EDDF6C45-9362-4B4F-8F64-AEA169CD18DAQ92942059-D3F4D1FA-4A2A-45B4-91FD-C93A88EA25C3Q96339758-BCC2357C-87CB-44F5-88C3-2CDAF70AB1B9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vittal Mogasale
@ast
Vittal Mogasale
@en
Vittal Mogasale
@es
Vittal Mogasale
@nl
type
label
Vittal Mogasale
@ast
Vittal Mogasale
@en
Vittal Mogasale
@es
Vittal Mogasale
@nl
prefLabel
Vittal Mogasale
@ast
Vittal Mogasale
@en
Vittal Mogasale
@es
Vittal Mogasale
@nl
P106
P1153
15020854400
P31
P496
0000-0003-0596-8072